(BNTX) BioNTech SE - Performance 2% in 12m
Compare BNTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
28.17%
#23 in Group
Rel. Strength
46.08%
#4120 in Universe
Total Return 12m
1.96%
#39 in Group
Total Return 5y
79.32%
#24 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 7.04
34th Percentile in Group
PEG 0.04
50th Percentile in Group
FCF Yield -5.33%
73th Percentile in Group
12m Total Return: BNTX (2%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: BNTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BNTX
Total Return (including Dividends) | BNTX | XBI | S&P 500 |
---|---|---|---|
1 Month | -16.35% | -5.85% | -3.01% |
3 Months | -19.06% | -11.95% | -3.15% |
12 Months | 1.96% | -11.00% | 10.19% |
5 Years | 79.32% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | BNTX | XBI | S&P 500 |
1 Month | -88.4% | -59.8% | -5.5% |
3 Months | -75.7% | -70.5% | -58.4% |
12 Months | 62.3% | -6.9% | 84.1% |
5 Years | -8.10% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #129 | -11.2% | -13.8% |
3 Month | #77 | -8.08% | -16.4% |
12 Month | #40 | 14.6% | -7.47% |
5 Years | #26 | 78.2% | -21.8% |
FAQs
Does BNTX BioNTech SE outperforms the market?
Yes,
over the last 12 months BNTX made 1.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months BNTX made -19.06%, while XBI made -11.95%.
Over the last 3 months BNTX made -19.06%, while XBI made -11.95%.
Performance Comparison BNTX vs Indeces and Sectors
BNTX vs. Indices BNTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.97% | -13.3% | -21.5% | -8.23% |
US NASDAQ 100 | QQQ | -0.99% | -12.3% | -20.7% | -6.64% |
US Dow Jones Industrial 30 | DIA | -2.17% | -14.2% | -22.4% | -7.55% |
German DAX 40 | DAX | -0.67% | -13.0% | -38.2% | -19.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.68% | -16.6% | -6.22% | -7.16% |
Hongkong Hang Seng | HSI | -3.94% | -19.1% | -12.2% | -15.4% |
India NIFTY 50 | INDA | -3.0% | -24.2% | -11.1% | 1.26% |
Brasil Bovespa | EWZ | -2.08% | -24.6% | -13.5% | 13.7% |
BNTX vs. Sectors BNTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.43% | -12.5% | -29.6% | -17.3% |
Consumer Discretionary | XLY | -2.73% | -12.5% | -24.8% | -12.1% |
Consumer Staples | XLP | -4.76% | -14.5% | -22.3% | -9.07% |
Energy | XLE | -3.06% | -24.4% | -27.0% | 1.15% |
Financial | XLF | -2.45% | -13.7% | -33.6% | -20.3% |
Health Care | XLV | -2.39% | -13.2% | -16.8% | 0.27% |
Industrial | XLI | -2.28% | -15.7% | -20.7% | -6.57% |
Materials | XLB | -3.07% | -16.9% | -13.3% | 5.90% |
Real Estate | XLRE | -4.01% | -13.7% | -18.3% | -11.4% |
Technology | XLK | -0.84% | -12.3% | -16.3% | -0.05% |
Utilities | XLU | -5.26% | -17.2% | -20.6% | -23.3% |
Aerospace & Defense | XAR | -1.37% | -17.6% | -25.4% | -19.0% |
Biotech | XBI | 2.59% | -10.5% | -3.75% | 13.0% |
Homebuilder | XHB | -2.47% | -16.5% | -2.07% | 9.66% |
Retail | XRT | -4.27% | -15.9% | -17.4% | 6.75% |